vs

Side-by-side financial comparison of GERON CORP (GERN) and LXP Industrial Trust (LXP). Click either name above to swap in a different company.

LXP Industrial Trust is the larger business by last-quarter revenue ($86.7M vs $47.2M, roughly 1.8× GERON CORP). LXP Industrial Trust runs the higher net margin — 33.2% vs -39.0%, a 72.2% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs -14.0%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 0.3%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.

GERN vs LXP — Head-to-Head

Bigger by revenue
LXP
LXP
1.8× larger
LXP
$86.7M
$47.2M
GERN
Growing faster (revenue YoY)
GERN
GERN
+81.0% gap
GERN
67.1%
-14.0%
LXP
Higher net margin
LXP
LXP
72.2% more per $
LXP
33.2%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
0.3%
LXP

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
LXP
LXP
Revenue
$47.2M
$86.7M
Net Profit
$-18.4M
$28.8M
Gross Margin
81.5%
Operating Margin
-29.4%
34.6%
Net Margin
-39.0%
33.2%
Revenue YoY
67.1%
-14.0%
Net Profit YoY
30.3%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
LXP
LXP
Q4 25
$86.7M
Q3 25
$47.2M
$86.9M
Q2 25
$49.0M
$87.7M
Q1 25
$39.6M
$88.9M
Q4 24
$100.9M
Q3 24
$28.3M
$85.6M
Q2 24
$882.0K
$85.8M
Q1 24
$304.0K
$86.3M
Net Profit
GERN
GERN
LXP
LXP
Q4 25
$28.8M
Q3 25
$-18.4M
$36.3M
Q2 25
$-16.4M
$29.1M
Q1 25
$-19.8M
$19.0M
Q4 24
Q3 24
$-26.4M
$6.3M
Q2 24
$-67.4M
$5.4M
Q1 24
$-55.4M
$-269.0K
Gross Margin
GERN
GERN
LXP
LXP
Q4 25
81.5%
Q3 25
82.3%
Q2 25
81.9%
Q1 25
80.7%
Q4 24
85.3%
Q3 24
82.5%
Q2 24
82.0%
Q1 24
82.4%
Operating Margin
GERN
GERN
LXP
LXP
Q4 25
34.6%
Q3 25
-29.4%
50.4%
Q2 25
-25.4%
33.7%
Q1 25
-42.2%
21.8%
Q4 24
Q3 24
-99.8%
7.9%
Q2 24
-7860.9%
6.9%
Q1 24
-18465.1%
1.0%
Net Margin
GERN
GERN
LXP
LXP
Q4 25
33.2%
Q3 25
-39.0%
41.7%
Q2 25
-33.4%
33.2%
Q1 25
-50.1%
21.4%
Q4 24
Q3 24
-93.5%
7.4%
Q2 24
-7639.8%
6.3%
Q1 24
-18220.4%
-0.3%
EPS (diluted)
GERN
GERN
LXP
LXP
Q4 25
Q3 25
$-0.03
$0.12
Q2 25
$-0.02
$0.09
Q1 25
$-0.03
$0.06
Q4 24
Q3 24
$-0.04
$0.02
Q2 24
$-0.10
$0.01
Q1 24
$-0.09
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
LXP
LXP
Cash + ST InvestmentsLiquidity on hand
$78.1M
$170.4M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$248.7M
$2.0B
Total Assets
$567.4M
$3.5B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
LXP
LXP
Q4 25
$170.4M
Q3 25
$78.1M
$229.7M
Q2 25
$77.7M
$71.0M
Q1 25
$83.7M
$70.9M
Q4 24
$101.8M
Q3 24
$60.3M
$55.0M
Q2 24
$116.9M
$48.7M
Q1 24
$189.8M
$293.8M
Total Debt
GERN
GERN
LXP
LXP
Q4 25
$1.4B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.6B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GERN
GERN
LXP
LXP
Q4 25
$2.0B
Q3 25
$248.7M
$2.1B
Q2 25
$259.5M
$2.1B
Q1 25
$268.2M
$2.1B
Q4 24
$2.1B
Q3 24
$292.3M
$2.1B
Q2 24
$306.7M
$2.1B
Q1 24
$344.9M
$2.2B
Total Assets
GERN
GERN
LXP
LXP
Q4 25
$3.5B
Q3 25
$567.4M
$3.7B
Q2 25
$555.2M
$3.7B
Q1 25
$562.5M
$3.8B
Q4 24
$3.8B
Q3 24
$444.9M
$3.9B
Q2 24
$449.4M
$3.9B
Q1 24
$482.1M
$4.2B
Debt / Equity
GERN
GERN
LXP
LXP
Q4 25
0.66×
Q3 25
0.72×
Q2 25
0.72×
Q1 25
0.73×
Q4 24
0.75×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
LXP
LXP
Operating Cash FlowLast quarter
$-13.6M
$188.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
6.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
LXP
LXP
Q4 25
$188.7M
Q3 25
$-13.6M
$63.5M
Q2 25
$-27.4M
$44.3M
Q1 25
$-48.0M
$39.0M
Q4 24
$211.2M
Q3 24
$-58.9M
$64.6M
Q2 24
$-53.5M
$38.5M
Q1 24
$-62.3M
$38.9M
Free Cash Flow
GERN
GERN
LXP
LXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
FCF Margin
GERN
GERN
LXP
LXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Capex Intensity
GERN
GERN
LXP
LXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
23.4%
Q1 24
202.3%
Cash Conversion
GERN
GERN
LXP
LXP
Q4 25
6.56×
Q3 25
1.75×
Q2 25
1.52×
Q1 25
2.05×
Q4 24
Q3 24
10.18×
Q2 24
7.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons